Research suggests that this bacterium can boost regulatoryT cells, which helps reduce intestinal inflammation.43 When compared to the UT and FT, the HFD group shows a significantincrease in E. coprostanoligenes (Figure 8E), a bacterium whose relativeabundance rises in individuals with type 2 diabetes and is directlyassociated with higher levels of serum TNF-α and TG.44,45 Furthermore, the HFD group exhibits a notable increase in R. faecis abundance compared to the FT group. This evidence concerns the gene TNF and type 2 diabetes mellitus.